ARDX
ARDELYX, INC.
NASDAQ · Healthcare · Biotechnology · US
$3.29
+8.58%Forward multiples
Based on analyst estimates
- P/E forward
- 67.30x
- P/E 2026E
- —
- P/E 2027E
- 13.33x
- P/E 2028E
- 3.90x
- P/S forward
- 1.51x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.04x
- Price / sales
- 1.77x
- Price / cash flow
- -53.31x
Enterprise value
- Enterprise value
- $798.0M
- EV / sales
- 1.70x
- EV / EBITDA
- -27.81x
- EV / EBIT
- -22.11x
- Market cap
- $827.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Sep 1, 2026